DIVIDEND ANNOUNCEMENT: Lilly (Eli) & Co (NYSE:LLY) on 12/12/2022 declared a dividend of $1.1300 per share

Lilly (Eli) & Co (NYSE:LLY) on 12/12/2022 declared a dividend of $ 1.1300 per share payable on March 10, 2023 to shareholders of record as of February 15, 2023. Dividend amount recorded is an increase of $ 0.15 from last dividend Paid.

Lilly (Eli) & Co (NYSE:LLY) has paid dividends since 1885, has a current dividend yield of 1.2521122694% and has increased its dividends for 7 successive years.

Lilly (Eli) & Co's market cap is $ 343,004,756,220 and has a PE ratio of 54.28. The stock price closed yesterday at $ 360.99 and has a 52 week low/high of $ 231.87 and $ 375.25.

Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.

For more information on Lilly (Eli) & Co click here.